COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung diseases that include emphysema and chronic bronchitis. 1 Those living with COPD can experience coughing, wheezing, ...
After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
Napa, CA (October 24, 2007) – Data from two Phase III clinical trials were presented today in Chicago at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians (ACCP), ...
Add Yahoo as a preferred source to see more of our stories on Google. Nov. 14—(StatePoint) If you're one of the 35 million people living with a chronic lung disease in the United States, the form of ...
Please provide your email address to receive an email when new articles are posted on . Maintenance treatment with nebulized revefenacin improves the health status of patients with moderate to very ...
For individuals living with COPD, small changes may make a difference. Byline: Viatris Inc. and Theravance Biopharma US, Inc. COPD, or chronic obstructive pulmonary disease, is a group of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results